Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05194228 · ClinicalTrials.gov registry record · NA
Exemplar: Determining the Best Practices for EMA Studies
A NA study, sponsored by University of Oklahoma.
- Completed
- Registry status
- NA
- Development phase
- 416
- Enrollment target
NCT05194228: Completed NA study, sponsored by University of Oklahoma.
NCT05194228 is a NA study that has completed, run by University of Oklahoma. The registered enrollment target is 416 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (70% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05194228, a NA study, has completed, sponsored by University of Oklahoma.
- COMPLETED
- Registry status
- NA
- Development phase
- 416 participants
- Enrollment target
Study Summary
Ecological momentary assessment (EMA) is a measurement methodology that utilizes the repeated collection of real-time data on participants' behavior and experience in their natural environment. While EMA allows researchers to gain valuable insights into dynamic behavioral processes, the need for frequent self-report can be burdensome and disruptive to participants. Compliance with EMA protocols is important for accurate, unbiased sampling, yet there is no "gold standard" for EMA study design. In the present study, the investigators aim to use a factorial design to identify the optimal components, or combinations of components, for achieving the highest compliance rates for smartphone-based ecological momentary assessments (EMAs). Participants will be randomized into 1 of 32 conditions in a 2x2x2x2x2 design (i.e., number of questions per EMA survey \[15 vs. 25\] x number of EMAs per day \[2 vs. 4\] x EMA prompting schedule \[random vs. fixed times\]) x payment type \[per EMA vs. based on percentage of EMAs completed\] x order of EMA item question types \[i.e., slider type first 2 weeks vs. Likert-type questions first 2 weeks\]). All participants will complete EMAs for 4 weeks. The effect of each factor on EMA compliance will be examined, as well as the effects of interactions on EMA compliance. The investigators will also examine within and between-subjects factors that influence response rates, and 2) contextual features such as environment and mood that may be associated with better compliance and participant engagement. The results of this study will have broad applications for developing best practices guidelines for future studies utilizing EMA methodologies.
Primary Outcome
Proportion of daily smartphone surveys completed will vary based upon group assignment.
Interventions
- BEHAVIORAL Ecologial Momentary Assessment settings
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 416 participants |
| Start Date | 2021-11-30 |
| Est. Completion | 2022-10-26 |
| Phase | NA |
What the finished NCT05194228 record still lists
NCT05194228 is an interventional study that assigns participants to a tested intervention. The registered 416 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (70% lower).
The record links to 0 conditions, and to 1 intervention - of which Ecologial Momentary Assessment settings is the first listed.
NCT05194228 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05194228 about?
NCT05194228 is a clinical study titled "Exemplar: Determining the Best Practices for EMA Studies". Ecological momentary assessment (EMA) is a measurement methodology that utilizes the repeated collection of real-time data on participants' behavior and experience in their natural environment. While EMA allows researchers to gain valuable insights into dynamic behavioral processes, the need for fre...
What is the current status of trial NCT05194228?
This trial is currently completed. It is a NA study. The enrollment target is 416 participants. The study started on 2021-11-30. Estimated completion is 2022-10-26.
What interventions are being tested in trial NCT05194228?
The interventions under investigation include: Ecologial Momentary Assessment settings (BEHAVIORAL).
Who is sponsoring clinical trial NCT05194228?
This trial is sponsored by University of Oklahoma, which has 358 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT05194228's enrollment target sits among peer trials
416 241st of 2000 higher than 1,760 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03527537 · 416 participants · Phase 4
Gestational Diabetes and Pharmacotherapy (GAP)
- NCT05007782 · 416 participants · Phase 1
Study of Denikitug (GS-1811) Given Alone or With Zimberelimab in Adults With Advanced Solid Tumors
- NCT05520099 · 416 participants
Observational Basket Trial to Collect Tissue to Develop and Train a Live Tumor Diagnostic Platform
- NCT06075745 · 416 participants · Phase 2
Cytomegalovirus (CMV) Vaccine in Orthotopic Liver Transplant Candidates
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI